Global Biobanking Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Biobanking Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Biobanking Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
  • 1.2.2 Equipment
  • 1.2.3 Consumable
• 1.3 Market by Application
  • 1.3.1 Global Biobanking Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
  • 1.3.2 Virtual Biobanks
  • 1.3.3 Tissue Biobanks
  • 1.3.4 Population Biobanks
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Biobanking Market Size Estimates and Forecasts
• 2.2 Biobanking Market Size by Region: 2024 Versus 2031
  • 2.2.1 Global Biobanking Revenue by Region: 2020-2025
  • 2.2.2 Global Biobanking Revenue Forecast by Region (2026-2031)
  • 2.2.3 Global Biobanking Revenue Market Share by Region (2020-2031)

3 Market Segments

• 3.1 Breakdown Data by Type
  • 3.1.1 Global Biobanking Revenue by Type (2020-2031)
  • 3.1.2 Global Biobanking Revenue Market Share by Type (2020-2031)
• 3.2 Breakdown Data by Application
  • 3.2.1 Global Biobanking Revenue by Application (2020-2031)
  • 3.2.2 Global Biobanking Revenue Market Share by Application (2020-2031)
• 3.3 by Type and by Application Crossing Analysis
  • 3.3.1 Equipment of Biobanking Revenue Market Share by Application
  • 3.3.2 Consumable of Biobanking Revenue Market Share by Application

4 Global Biobanking by Company

• 4.1 Global Biobanking Revenue by Company (2020-2025)
• 4.2 Global Biobanking Revenue Share by Company (2020-2025)
• 4.3 Competitive Landscape
  • 4.3.1 Key Biobanking Companies around the World: Ranking by Revenue
  • 4.3.2 Global Biobanking Market Concentration Ratio (CR5 and HHI) & (2020-2025)
  • 4.3.3 Global Biobanking Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.4 Global Biobanking Companies Headquarters & Product Type
  • 4.4.1 Global Biobanking Companies Headquarters
  • 4.4.2 Date of International Companies Enter into Biobanking Market
  • 4.4.3 Global Biobanking Companies Product & Service
  • 4.4.4 Equipment Revenue Market Share of Biobanking by Company
  • 4.4.5 Consumable Revenue Market Share of Biobanking by Company
• 4.5 Global Biobanking Mergers & Acquisitions, Expansion Plans

5 Company Profiles

• 5.1 Thermo Fisher
  • 5.1.1 Thermo Fisher Corporation Information
  • 5.1.2 Thermo Fisher Description, Business Overview
  • 5.1.3 Thermo Fisher Biobanking Products Offered
  • 5.1.4 Thermo Fisher Biobanking Revenue and Gross Margin (2020-2025)
  • 5.1.5 Thermo Fisher Biobanking Revenue by Product in 2024
  • 5.1.6 Thermo Fisher Biobanking Revenue by Application in 2024
  • 5.1.7 Thermo Fisher Biobanking Revenue by Geographic Area in 2024
  • 5.1.8 Thermo Fisher Recent Developments
• 5.2 Beckman Coulter
  • 5.2.1 Beckman Coulter Corporation Information
  • 5.2.2 Beckman Coulter Description, Business Overview
  • 5.2.3 Beckman Coulter Biobanking Products Offered
  • 5.2.4 Beckman Coulter Biobanking Revenue and Gross Margin (2020-2025)
  • 5.2.5 Beckman Coulter Biobanking Revenue by Product in 2024
  • 5.2.6 Beckman Coulter Biobanking Revenue by Application in 2024
  • 5.2.7 Beckman Coulter Biobanking Revenue by Geographic Area in 2024
  • 5.2.8 Beckman Coulter Recent Developments
• 5.3 Panasonic
  • 5.3.1 Panasonic Corporation Information
  • 5.3.2 Panasonic Description, Business Overview
  • 5.3.3 Panasonic Biobanking Products Offered
  • 5.3.4 Panasonic Biobanking Revenue and Gross Margin (2020-2025)
  • 5.3.5 Panasonic Biobanking Revenue by Product in 2024
  • 5.3.6 Panasonic Biobanking Revenue by Application in 2024
  • 5.3.7 Panasonic Biobanking Revenue by Geographic Area in 2024
  • 5.3.8 Panasonic Recent Developments
• 5.4 SOL Group
  • 5.4.1 SOL Group Corporation Information
  • 5.4.2 SOL Group Description, Business Overview
  • 5.4.3 SOL Group Biobanking Products Offered
  • 5.4.4 SOL Group Biobanking Revenue and Gross Margin (2020-2025)
  • 5.4.5 SOL Group Biobanking Revenue by Product in 2024
  • 5.4.6 SOL Group Biobanking Revenue by Application in 2024
  • 5.4.7 SOL Group Biobanking Revenue by Geographic Area in 2024
  • 5.4.8 SOL Group Recent Developments
• 5.5 Promega
  • 5.5.1 Promega Corporation Information
  • 5.5.2 Promega Description, Business Overview
  • 5.5.3 Promega Biobanking Products Offered
  • 5.5.4 Promega Biobanking Revenue and Gross Margin (2020-2025)
  • 5.5.5 Promega Biobanking Revenue by Product in 2024
  • 5.5.6 Promega Biobanking Revenue by Application in 2024
  • 5.5.7 Promega Biobanking Revenue by Geographic Area in 2024
  • 5.5.8 Promega Recent Developments
• 5.6 Merck
  • 5.6.1 Merck Corporation Information
  • 5.6.2 Merck Description, Business Overview
  • 5.6.3 Merck Biobanking Products Offered
  • 5.6.4 Merck Biobanking Revenue and Gross Margin (2020-2025)
  • 5.6.5 Merck Biobanking Revenue by Product in 2024
  • 5.6.6 Merck Biobanking Revenue by Application in 2024
  • 5.6.7 Merck Biobanking Revenue by Geographic Area in 2024
  • 5.6.8 Merck Recent Developments
• 5.7 Greiner Bio One
  • 5.7.1 Greiner Bio One Corporation Information
  • 5.7.2 Greiner Bio One Description, Business Overview
  • 5.7.3 Greiner Bio One Biobanking Products Offered
  • 5.7.4 Greiner Bio One Biobanking Revenue and Gross Margin (2020-2025)
  • 5.7.5 Greiner Bio One Biobanking Revenue by Product in 2024
  • 5.7.6 Greiner Bio One Biobanking Revenue by Application in 2024
  • 5.7.7 Greiner Bio One Biobanking Revenue by Geographic Area in 2024
  • 5.7.8 Greiner Bio One Recent Developments
• 5.8 Chart Industries
  • 5.8.1 Chart Industries Corporation Information
  • 5.8.2 Chart Industries Description, Business Overview
  • 5.8.3 Chart Industries Biobanking Products Offered
  • 5.8.4 Chart Industries Biobanking Revenue and Gross Margin (2020-2025)
  • 5.8.5 Chart Industries Biobanking Revenue by Product in 2024
  • 5.8.6 Chart Industries Biobanking Revenue by Application in 2024
  • 5.8.7 Chart Industries Biobanking Revenue by Geographic Area in 2024
  • 5.8.8 Chart Industries Recent Developments
• 5.9 Brooks Life Science
  • 5.9.1 Brooks Life Science Corporation Information
  • 5.9.2 Brooks Life Science Description, Business Overview
  • 5.9.3 Brooks Life Science Biobanking Products Offered
  • 5.9.4 Brooks Life Science Biobanking Revenue and Gross Margin (2020-2025)
  • 5.9.5 Brooks Life Science Biobanking Revenue by Product in 2024
  • 5.9.6 Brooks Life Science Biobanking Revenue by Application in 2024
  • 5.9.7 Brooks Life Science Biobanking Revenue by Geographic Area in 2024
  • 5.9.8 Brooks Life Science Recent Developments
• 5.10 Tecan Group
  • 5.10.1 Tecan Group Corporation Information
  • 5.10.2 Tecan Group Description, Business Overview
  • 5.10.3 Tecan Group Biobanking Products Offered
  • 5.10.4 Tecan Group Biobanking Revenue and Gross Margin (2020-2025)
  • 5.10.5 Tecan Group Biobanking Revenue by Product in 2024
  • 5.10.6 Tecan Group Biobanking Revenue by Application in 2024
  • 5.10.7 Tecan Group Biobanking Revenue by Geographic Area in 2024
  • 5.10.8 Tecan Group Recent Developments
• 5.11 QIAGEN
  • 5.11.1 QIAGEN Corporation Information
  • 5.11.2 QIAGEN Description, Business Overview
  • 5.11.3 QIAGEN Biobanking Products Offered
  • 5.11.4 QIAGEN Biobanking Revenue and Gross Margin (2020-2025)
  • 5.11.5 QIAGEN Biobanking Revenue by Product in 2024
  • 5.11.6 QIAGEN Biobanking Revenue by Application in 2024
  • 5.11.7 QIAGEN Biobanking Revenue by Geographic Area in 2024
  • 5.11.8 QIAGEN Recent Developments
• 5.12 BD
  • 5.12.1 BD Corporation Information
  • 5.12.2 BD Description, Business Overview
  • 5.12.3 BD Biobanking Products Offered
  • 5.12.4 BD Biobanking Revenue and Gross Margin (2020-2025)
  • 5.12.5 BD Biobanking Revenue by Product in 2024
  • 5.12.6 BD Biobanking Revenue by Application in 2024
  • 5.12.7 BD Biobanking Revenue by Geographic Area in 2024
  • 5.12.8 BD Recent Developments
• 5.13 Lifeline Scientific
  • 5.13.1 Lifeline Scientific Corporation Information
  • 5.13.2 Lifeline Scientific Description, Business Overview
  • 5.13.3 Lifeline Scientific Biobanking Products Offered
  • 5.13.4 Lifeline Scientific Biobanking Revenue and Gross Margin (2020-2025)
  • 5.13.5 Lifeline Scientific Biobanking Revenue by Product in 2024
  • 5.13.6 Lifeline Scientific Biobanking Revenue by Application in 2024
  • 5.13.7 Lifeline Scientific Biobanking Revenue by Geographic Area in 2024
  • 5.13.8 Lifeline Scientific Recent Developments
• 5.14 Hamilton
  • 5.14.1 Hamilton Corporation Information
  • 5.14.2 Hamilton Description, Business Overview
  • 5.14.3 Hamilton Biobanking Products Offered
  • 5.14.4 Hamilton Biobanking Revenue and Gross Margin (2020-2025)
  • 5.14.5 Hamilton Biobanking Revenue by Product in 2024
  • 5.14.6 Hamilton Biobanking Revenue by Application in 2024
  • 5.14.7 Hamilton Biobanking Revenue by Geographic Area in 2024
  • 5.14.8 Hamilton Recent Developments
• 5.15 So-Low
  • 5.15.1 So-Low Corporation Information
  • 5.15.2 So-Low Description, Business Overview
  • 5.15.3 So-Low Biobanking Products Offered
  • 5.15.4 So-Low Biobanking Revenue and Gross Margin (2020-2025)
  • 5.15.5 So-Low Biobanking Revenue by Product in 2024
  • 5.15.6 So-Low Biobanking Revenue by Application in 2024
  • 5.15.7 So-Low Biobanking Revenue by Geographic Area in 2024
  • 5.15.8 So-Low Recent Developments
• 5.16 TTP Labtech Ltd
  • 5.16.1 TTP Labtech Ltd Corporation Information
  • 5.16.2 TTP Labtech Ltd Description, Business Overview
  • 5.16.3 TTP Labtech Ltd Biobanking Products Offered
  • 5.16.4 TTP Labtech Ltd Biobanking Revenue and Gross Margin (2020-2025)
  • 5.16.5 TTP Labtech Ltd Biobanking Revenue by Product in 2024
  • 5.16.6 TTP Labtech Ltd Biobanking Revenue by Application in 2024
  • 5.16.7 TTP Labtech Ltd Biobanking Revenue by Geographic Area in 2024
  • 5.16.8 TTP Labtech Ltd Recent Developments
• 5.17 Biolife Solutions
  • 5.17.1 Biolife Solutions Corporation Information
  • 5.17.2 Biolife Solutions Description, Business Overview
  • 5.17.3 Biolife Solutions Biobanking Products Offered
  • 5.17.4 Biolife Solutions Biobanking Revenue and Gross Margin (2020-2025)
  • 5.17.5 Biolife Solutions Biobanking Revenue by Product in 2024
  • 5.17.6 Biolife Solutions Biobanking Revenue by Application in 2024
  • 5.17.7 Biolife Solutions Biobanking Revenue by Geographic Area in 2024
  • 5.17.8 Biolife Solutions Recent Developments
• 5.18 DNA Genotek
  • 5.18.1 DNA Genotek Corporation Information
  • 5.18.2 DNA Genotek Description, Business Overview
  • 5.18.3 DNA Genotek Biobanking Products Offered
  • 5.18.4 DNA Genotek Biobanking Revenue and Gross Margin (2020-2025)
  • 5.18.5 DNA Genotek Biobanking Revenue by Product in 2024
  • 5.18.6 DNA Genotek Biobanking Revenue by Application in 2024
  • 5.18.7 DNA Genotek Biobanking Revenue by Geographic Area in 2024
  • 5.18.8 DNA Genotek Recent Developments
• 5.19 Custom Biogenic Systems
  • 5.19.1 Custom Biogenic Systems Corporation Information
  • 5.19.2 Custom Biogenic Systems Description, Business Overview
  • 5.19.3 Custom Biogenic Systems Biobanking Products Offered
  • 5.19.4 Custom Biogenic Systems Biobanking Revenue and Gross Margin (2020-2025)
  • 5.19.5 Custom Biogenic Systems Biobanking Revenue by Product in 2024
  • 5.19.6 Custom Biogenic Systems Biobanking Revenue by Application in 2024
  • 5.19.7 Custom Biogenic Systems Biobanking Revenue by Geographic Area in 2024
  • 5.19.8 Custom Biogenic Systems Recent Developments
• 5.20 LVL Technologies
  • 5.20.1 LVL Technologies Corporation Information
  • 5.20.2 LVL Technologies Description, Business Overview
  • 5.20.3 LVL Technologies Biobanking Products Offered
  • 5.20.4 LVL Technologies Biobanking Revenue and Gross Margin (2020-2025)
  • 5.20.5 LVL Technologies Biobanking Revenue by Product in 2024
  • 5.20.6 LVL Technologies Biobanking Revenue by Application in 2024
  • 5.20.7 LVL Technologies Biobanking Revenue by Geographic Area in 2024
  • 5.20.8 LVL Technologies Recent Developments
• 5.21 BioRep
  • 5.21.1 BioRep Corporation Information
  • 5.21.2 BioRep Description, Business Overview
  • 5.21.3 BioRep Biobanking Products Offered
  • 5.21.4 BioRep Biobanking Revenue and Gross Margin (2020-2025)
  • 5.21.5 BioRep Biobanking Revenue by Product in 2024
  • 5.21.6 BioRep Biobanking Revenue by Application in 2024
  • 5.21.7 BioRep Biobanking Revenue by Geographic Area in 2024
  • 5.21.8 BioRep Recent Developments

6 North America

• 6.1 North America Biobanking Market Size YoY Growth 2020-2031
• 6.2 North America Biobanking Market Facts & Figures by Country (2020-2031)
• 6.3 North America Biobanking Revenue by Type (2020-2025)
• 6.4 North America Biobanking Revenue by Application (2020-2025)

7 Asia-Pacific

• 7.1 Asia-Pacific Biobanking Market Size YoY Growth 2020-2031
• 7.2 Asia-Pacific Biobanking Market Facts & Figures by Region (2020-2031)
• 7.3 Asia-Pacific Biobanking Revenue by Type (2020-2025)
• 7.4 Asia-Pacific Biobanking Revenue by Application (2020-2025)

8 Europe

• 8.1 Europe Biobanking Market Size YoY Growth 2020-2031
• 8.2 Europe Biobanking Market Facts & Figures by Country (2020-2031)
• 8.3 Europe Biobanking Revenue by Type (2020-2025)
• 8.4 Europe Biobanking Revenue by Application (2020-2025)

9 Latin America

• 9.1 Latin America Biobanking Market Size YoY Growth 2020-2031
• 9.2 Latin America Biobanking Market Facts & Figures by Country (2020-2031)
• 9.3 Latin America Biobanking Revenue by Type (2020-2025)
• 9.4 Latin America Biobanking Revenue by Application (2020-2025)

10 Middle East and Africa

• 10.1 Latin America Biobanking Market Size YoY Growth 2020-2031
• 10.2 Middle East and Africa Biobanking Market Facts & Figures by Country (2020-2031)
• 10.3 Middle East and Africa Biobanking Revenue by Type (2020-2025)
• 10.4 Middle East and Africa Biobanking Revenue by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

• 11.1 Biobanking Supply Chain Analysis
• 11.2 Biobanking Key Raw Materials and Upstream Suppliers
• 11.3 Biobanking Clients Analysis
• 11.4 Biobanking Sales Channel and Sales Model Analysis
  • 11.4.1 Biobanking Distribution Channel Analysis: Indirect Sales VS Direct Sales
  • 11.4.2 Biobanking Distribution Channel Analysis: Online Sales VS Offline Sales
  • 11.4.3 Biobanking Distributors

12 Biobanking Market Dynamics

• 12.1 Biobanking Industry Trends
• 12.2 Biobanking Market Drivers
• 12.3 Biobanking Market Challenges
• 12.4 Biobanking Market Restraints

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details
• 14.3 Disclaimer

List of Tables

Table 1. Global Biobanking Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Biobanking Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Biobanking Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Biobanking Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Biobanking Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 6. Global Biobanking Revenue by Type (2020-2025) & (US$ Million)

Table 7. Global Biobanking Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 8. Global Biobanking Revenue by Application (2020-2025) & (US$ Million)

Table 9. Global Biobanking Revenue Forecast by Application (2026-2031) & (US$ Million)

Table 10. Biobanking Revenue by Company (2020-2025) & (US$ Million)

Table 11. Biobanking Revenue Share by Company (2020-2025)

Table 12. Ranking of Global Top Biobanking Players by Revenue (US$ Million) in 2024

Table 13. Global Biobanking Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 14. Global Biobanking by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biobanking as of 2024)

Table 15. Global Biobanking Companies Headquarters

Table 16. Date of International Companies Enter into Biobanking Market

Table 17. Global Biobanking Companies Product & Service

Table 18. Global Biobanking Mergers & Acquisitions, Expansion Plans

Table 19. Thermo Fisher Corporation Information

Table 20. Thermo Fisher Description and Business Overview

Table 21. Thermo Fisher Biobanking Product

Table 22. Thermo Fisher Biobanking Revenue (US$ Million) and Gross Margin (2020-2025)

Table 23. Thermo Fisher Revenue Proportion of Biobanking by Product in 2024

Table 24. Thermo Fisher Revenue Proportion of Biobanking by Application in 2024

Table 25. Thermo Fisher Revenue Proportion of Biobanking by Geographic Area in 2024

Table 26. Thermo Fisher Recent Developments

Table 27. Beckman Coulter Corporation Information

Table 28. Beckman Coulter Description and Business Overview

Table 29. Beckman Coulter Biobanking Product

Table 30. Beckman Coulter Biobanking Revenue (US$ Million) and Gross Margin (2020-2025)

Table 31. Beckman Coulter Revenue Proportion of Biobanking by Product in 2024

Table 32. Beckman Coulter Revenue Proportion of Biobanking by Application in 2024

Table 33. Beckman Coulter Revenue Proportion of Biobanking by Geographic Area in 2024

Table 34. Beckman Coulter Recent Developments

Table 35. Panasonic Corporation Information

Table 36. Panasonic Description and Business Overview

Table 37. Panasonic Biobanking Product

Table 38. Panasonic Biobanking Revenue (US$ Million) and Gross Margin (2020-2025)

Table 39. Panasonic Revenue Proportion of Biobanking by Product in 2024

Table 40. Panasonic Revenue Proportion of Biobanking by Application in 2024

Table 41. Panasonic Revenue Proportion of Biobanking by Geographic Area in 2024

Table 42. Panasonic Recent Developments

Table 43. SOL Group Corporation Information

Table 44. SOL Group Description and Business Overview

Table 45. SOL Group Biobanking Product

Table 46. SOL Group Biobanking Revenue (US$ Million) and Gross Margin (2020-2025)

Table 47. SOL Group Revenue Proportion of Biobanking by Product in 2024

Table 48. SOL Group Revenue Proportion of Biobanking by Application in 2024

Table 49. SOL Group Revenue Proportion of Biobanking by Geographic Area in 2024

Table 50. SOL Group Recent Developments

Table 51. Promega Corporation Information

Table 52. Promega Description and Business Overview

Table 53. Promega Biobanking Product

Table 54. Promega Biobanking Revenue (US$ Million) and Gross Margin (2020-2025)

Table 55. Promega Revenue Proportion of Biobanking by Product in 2024

Table 56. Promega Revenue Proportion of Biobanking by Application in 2024

Table 57. Promega Revenue Proportion of Biobanking by Geographic Area in 2024

Table 58. Promega Recent Developments

Table 59. Merck Corporation Information

Table 60. Merck Description and Business Overview

Table 61. Merck Biobanking Product

Table 62. Merck Biobanking Revenue (US$ Million) and Gross Margin (2020-2025)

Table 63. Merck Revenue Proportion of Biobanking by Product in 2024

Table 64. Merck Revenue Proportion of Biobanking by Application in 2024

Table 65. Merck Revenue Proportion of Biobanking by Geographic Area in 2024

Table 66. Merck Recent Developments

Table 67. Greiner Bio One Corporation Information

Table 68. Greiner Bio One Description and Business Overview

Table 69. Greiner Bio One Biobanking Product

Table 70. Greiner Bio One Biobanking Revenue (US$ Million) and Gross Margin (2020-2025)

Table 71. Greiner Bio One Revenue Proportion of Biobanking by Product in 2024

Table 72. Greiner Bio One Revenue Proportion of Biobanking by Application in 2024

Table 73. Greiner Bio One Revenue Proportion of Biobanking by Geographic Area in 2024

Table 74. Greiner Bio One Recent Developments

Table 75. Chart Industries Corporation Information

Table 76. Chart Industries Description and Business Overview

Table 77. Chart Industries Biobanking Product

Table 78. Chart Industries Biobanking Revenue (US$ Million) and Gross Margin (2020-2025)

Table 79. Chart Industries Revenue Proportion of Biobanking by Product in 2024

Table 80. Chart Industries Revenue Proportion of Biobanking by Application in 2024

Table 81. Chart Industries Revenue Proportion of Biobanking by Geographic Area in 2024

Table 82. Chart Industries Recent Developments

Table 83. Brooks Life Science Corporation Information

Table 84. Brooks Life Science Description and Business Overview

Table 85. Brooks Life Science Biobanking Product

Table 86. Brooks Life Science Biobanking Revenue (US$ Million) and Gross Margin (2020-2025)

Table 87. Brooks Life Science Revenue Proportion of Biobanking by Product in 2024

Table 88. Brooks Life Science Revenue Proportion of Biobanking by Application in 2024

Table 89. Brooks Life Science Revenue Proportion of Biobanking by Geographic Area in 2024

Table 90. Brooks Life Science Recent Developments

Table 91. Tecan Group Corporation Information

Table 92. Tecan Group Description and Business Overview

Table 93. Tecan Group Biobanking Product

Table 94. Tecan Group Biobanking Revenue (US$ Million) and Gross Margin (2020-2025)

Table 95. Tecan Group Revenue Proportion of Biobanking by Product in 2024

Table 96. Tecan Group Revenue Proportion of Biobanking by Application in 2024

Table 97. Tecan Group Revenue Proportion of Biobanking by Geographic Area in 2024

Table 98. Tecan Group Recent Developments

Table 99. QIAGEN Corporation Information

Table 100. QIAGEN Description and Business Overview

Table 101. QIAGEN Biobanking Product

Table 102. QIAGEN Biobanking Revenue (US$ Million) and Gross Margin (2020-2025)

Table 103. QIAGEN Revenue Proportion of Biobanking by Product in 2024

Table 104. QIAGEN Revenue Proportion of Biobanking by Application in 2024

Table 105. QIAGEN Revenue Proportion of Biobanking by Geographic Area in 2024

Table 106. QIAGEN Recent Developments

Table 107. BD Corporation Information

Table 108. BD Description and Business Overview

Table 109. BD Biobanking Product

Table 110. BD Biobanking Revenue (US$ Million) and Gross Margin (2020-2025)

Table 111. BD Revenue Proportion of Biobanking by Product in 2024

Table 112. BD Revenue Proportion of Biobanking by Application in 2024

Table 113. BD Revenue Proportion of Biobanking by Geographic Area in 2024

Table 114. BD Recent Developments

Table 115. Lifeline Scientific Corporation Information

Table 116. Lifeline Scientific Description and Business Overview

Table 117. Lifeline Scientific Biobanking Product

Table 118. Lifeline Scientific Biobanking Revenue (US$ Million) and Gross Margin (2020-2025)

Table 119. Lifeline Scientific Revenue Proportion of Biobanking by Product in 2024

Table 120. Lifeline Scientific Revenue Proportion of Biobanking by Application in 2024

Table 121. Lifeline Scientific Revenue Proportion of Biobanking by Geographic Area in 2024

Table 122. Lifeline Scientific Recent Developments

Table 123. Hamilton Corporation Information

Table 124. Hamilton Description and Business Overview

Table 125. Hamilton Biobanking Product

Table 126. Hamilton Biobanking Revenue (US$ Million) and Gross Margin (2020-2025)

Table 127. Hamilton Revenue Proportion of Biobanking by Product in 2024

Table 128. Hamilton Revenue Proportion of Biobanking by Application in 2024

Table 129. Hamilton Revenue Proportion of Biobanking by Geographic Area in 2024

Table 130. Hamilton Recent Developments

Table 131. So-Low Corporation Information

Table 132. So-Low Description and Business Overview

Table 133. So-Low Biobanking Product

Table 134. So-Low Biobanking Revenue (US$ Million) and Gross Margin (2020-2025)

Table 135. So-Low Revenue Proportion of Biobanking by Product in 2024

Table 136. So-Low Revenue Proportion of Biobanking by Application in 2024

Table 137. So-Low Revenue Proportion of Biobanking by Geographic Area in 2024

Table 138. So-Low Recent Developments

Table 139. TTP Labtech Ltd Corporation Information

Table 140. TTP Labtech Ltd Description and Business Overview

Table 141. TTP Labtech Ltd Biobanking Product

Table 142. TTP Labtech Ltd Biobanking Revenue (US$ Million) and Gross Margin (2020-2025)

Table 143. TTP Labtech Ltd Revenue Proportion of Biobanking by Product in 2024

Table 144. TTP Labtech Ltd Revenue Proportion of Biobanking by Application in 2024

Table 145. TTP Labtech Ltd Revenue Proportion of Biobanking by Geographic Area in 2024

Table 146. TTP Labtech Ltd Recent Developments

Table 147. Biolife Solutions Corporation Information

Table 148. Biolife Solutions Description and Business Overview

Table 149. Biolife Solutions Biobanking Product

Table 150. Biolife Solutions Biobanking Revenue (US$ Million) and Gross Margin (2020-2025)

Table 151. Biolife Solutions Revenue Proportion of Biobanking by Product in 2024

Table 152. Biolife Solutions Revenue Proportion of Biobanking by Application in 2024

Table 153. Biolife Solutions Revenue Proportion of Biobanking by Geographic Area in 2024

Table 154. Biolife Solutions Recent Developments

Table 155. DNA Genotek Corporation Information

Table 156. DNA Genotek Description and Business Overview

Table 157. DNA Genotek Biobanking Product

Table 158. DNA Genotek Biobanking Revenue (US$ Million) and Gross Margin (2020-2025)

Table 159. DNA Genotek Revenue Proportion of Biobanking by Product in 2024

Table 160. DNA Genotek Revenue Proportion of Biobanking by Application in 2024

Table 161. DNA Genotek Revenue Proportion of Biobanking by Geographic Area in 2024

Table 162. DNA Genotek Recent Developments

Table 163. Custom Biogenic Systems Corporation Information

Table 164. Custom Biogenic Systems Description and Business Overview

Table 165. Custom Biogenic Systems Biobanking Product

Table 166. Custom Biogenic Systems Biobanking Revenue (US$ Million) and Gross Margin (2020-2025)

Table 167. Custom Biogenic Systems Revenue Proportion of Biobanking by Product in 2024

Table 168. Custom Biogenic Systems Revenue Proportion of Biobanking by Application in 2024

Table 169. Custom Biogenic Systems Revenue Proportion of Biobanking by Geographic Area in 2024

Table 170. Custom Biogenic Systems Recent Developments

Table 171. LVL Technologies Corporation Information

Table 172. LVL Technologies Description and Business Overview

Table 173. LVL Technologies Biobanking Product

Table 174. LVL Technologies Biobanking Revenue (US$ Million) and Gross Margin (2020-2025)

Table 175. LVL Technologies Revenue Proportion of Biobanking by Product in 2024

Table 176. LVL Technologies Revenue Proportion of Biobanking by Application in 2024

Table 177. LVL Technologies Revenue Proportion of Biobanking by Geographic Area in 2024

Table 178. LVL Technologies Recent Developments

Table 179. BioRep Corporation Information

Table 180. BioRep Description and Business Overview

Table 181. BioRep Biobanking Product

Table 182. BioRep Biobanking Revenue (US$ Million) and Gross Margin (2020-2025)

Table 183. BioRep Revenue Proportion of Biobanking by Product in 2024

Table 184. BioRep Revenue Proportion of Biobanking by Application in 2024

Table 185. BioRep Revenue Proportion of Biobanking by Geographic Area in 2024

Table 186. BioRep Recent Developments

Table 187. North America Biobanking Revenue by Country (2020-2025) & (US$ Million)

Table 188. North America Biobanking Revenue by Country (2026-2031) & (US$ Million)

Table 189. North America Biobanking Revenue by Type (2020-2025) & (US$ Million)

Table 190. North America Biobanking Revenue by Application (2020-2025) & (US$ Million)

Table 191. Asia-Pacific Biobanking Revenue by Region (2020-2025) & (US$ Million)

Table 192. Asia-Pacific Biobanking Revenue by Region (2026-2031) & (US$ Million)

Table 193. Asia-Pacific Biobanking Revenue by Type (2020-2025) & (US$ Million)

Table 194. Asia-Pacific Biobanking Revenue by Application (2020-2025) & (US$ Million)

Table 195. Europe Biobanking Revenue by Country (2020-2025) & (US$ Million)

Table 196. Europe Biobanking Revenue by Country (2026-2031) & (US$ Million)

Table 197. Europe Biobanking Revenue by Type (2020-2025) & (US$ Million)

Table 198. Europe Biobanking Revenue by Application (2020-2025) & (US$ Million)

Table 199. Latin America Biobanking Revenue by Country (2020-2025) & (US$ Million)

Table 200. Latin America Biobanking Revenue by Country (2026-2031) & (US$ Million)

Table 201. Latin America Biobanking Revenue by Type (2020-2025) & (US$ Million)

Table 202. Latin America Biobanking Revenue by Application (2020-2025) & (US$ Million)

Table 203. Middle East and Africa Biobanking Revenue by Country (2020-2025) & (US$ Million)

Table 204. Middle East and Africa Biobanking Revenue by Country (2026-2031) & (US$ Million)

Table 205. Middle East and Africa Biobanking Revenue by Type (2020-2025) & (US$ Million)

Table 206. Middle East and Africa Biobanking Revenue by Application (2020-2025) & (US$ Million)

Table 207. Biobanking Key Raw Materials, Industry Status and Trend

Table 208. Biobanking Key Raw Materials and Upstream Suppliers

Table 209. Biobanking Clients Status and Trend

Table 210. Biobanking Typical Clients

Table 211. Biobanking Distributors

Table 212. Biobanking Market Trends

Table 213. Biobanking Market Drivers

Table 214. Biobanking Market Challenges

Table 215. Biobanking Market Restraints

Table 216. Research Programs/Design for This Report

Table 217. Key Data Information from Secondary Sources

Table 218. Key Data Information from Primary Sources

List of Figures

Figure 1. Biobanking Product Picture

Figure 2. Global Biobanking Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Biobanking Revenue Market Share by Type in 2024 & 2031

Figure 4. Equipment Product Picture

Figure 5. Consumable Product Picture

Figure 6. Global Biobanking Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 7. Global Biobanking Revenue Market Share by Application in 2024 & 2031

Figure 8. Virtual Biobanks

Figure 9. Tissue Biobanks

Figure 10. Population Biobanks

Figure 11. Biobanking Report Years Considered

Figure 12. Global Biobanking Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Biobanking Market Size (2020-2031) & (US$ Million)

Figure 14. Global Biobanking Market Size Market Share by Region: 2024 Versus 2031

Figure 15. Global Biobanking Revenue Market Share by Region (2020-2031)

Figure 16. Global Biobanking Revenue Market Share Forecast by Type (2020-2031)

Figure 17. Global Biobanking Revenue Market Share Forecast by Application (2020-2031)

Figure 18. Equipment of Biobanking Revenue Market Share by Application, 2024 VS 2031

Figure 19. Consumable of Biobanking Revenue Market Share by Application, 2024 VS 2031

Figure 20. Biobanking Revenue Share by Company (2024)

Figure 21. Biobanking Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Equipment Revenue Proportion by Company in 2024

Figure 23. Consumable Revenue Proportion by Company in 2024

Figure 24. North America Biobanking Revenue 2020-2031 (US$ Million)

Figure 25. North America Biobanking Revenue Market Share by Type (2020-2025)

Figure 26. North America Biobanking Revenue Market Share by Application (2020-2025)

Figure 27. Asia-Pacific Biobanking Revenue 2020-2031 (US$ Million)

Figure 28. Asia-Pacific Biobanking Revenue Market Share by Region (2020-2031)

Figure 29. Asia-Pacific Biobanking Revenue Market Share by Type (2020-2025)

Figure 30. Asia-Pacific Biobanking Revenue Market Share by Application (2020-2025)

Figure 31. Europe Biobanking Revenue Growth Rate 2020-2031 (US$ Million)

Figure 32. Europe Biobanking Revenue Market Share by Country (2020-2031)

Figure 33. Europe Biobanking Revenue Market Share by Type (2020-2025)

Figure 34. Europe Biobanking Revenue Market Share by Application (2020-2025)

Figure 35. Latin America Biobanking Revenue Growth Rate 2020-2031 (US$ Million)

Figure 36. Latin America Biobanking Revenue Market Share by Country (2020-2031)

Figure 37. Latin America Biobanking Revenue Market Share by Type (2020-2025)

Figure 38. Latin America Biobanking Revenue Market Share by Application (2020-2025)

Figure 39. Middle East and Africa Biobanking Revenue Growth Rate 2020-2031 (US$ Million)

Figure 40. Middle East and Africa Biobanking Revenue Market Share by Country (2020-2031)

Figure 41. Middle East and Africa Biobanking Revenue Market Share by Type (2020-2025)

Figure 42. Middle East and Africa Biobanking Revenue Market Share by Application (2020-2025)

Figure 43. Biobanking Supply Chain (Upstream and Downstream Market)

Figure 44. Global Production Market Share of Biobanking Raw Materials by Region in 2024

Figure 45. Biobanking Distribution Channels

Figure 46. Global Biobanking Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 47. Global Biobanking Percentage 2020-2031: Online Sales VS Offline Sales

Figure 48. Bottom-up and Top-down Approaches for This Report

Figure 49. Data Triangulation

Figure 50. Key Executives Interviewed